A smart flower-like polymeric micelle for pH-triggered anticancer drug release

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Drug Delivery Systems

Background:

• Developing effective drug carriers is crucial for targeted therapy.
• pH-responsive drug delivery systems can enhance therapeutic efficacy by releasing drugs at specific sites.
• Tumor microenvironments often exhibit slightly acidic extracellular pH (pH(e)), presenting an opportunity for targeted drug release.

Purpose of the Study:

• To develop novel pH-responsive, flower-like micelles for triggered drug release.
• To investigate the self-assembly and pH-responsive behavior of poly(DEAP-Lys)-b-PEG-b-PLLA micelles.
• To evaluate the drug release profile of doxorubicin (DOX) from these micelles in response to pH changes.

Main Methods:

• Synthesis of poly(N(epsilon)-(3-diethylamino)propyl isothiocyanato-L-lysine)-b-poly(ethylene glycol)-b-poly(L-lactide) [poly(DEAP-Lys)-b-PEG-b-PLLA].
• Characterization of micelle particle size and critical micelle concentration (CMC).
• In vitro drug release studies using doxorubicin (DOX) under varying pH conditions.

Main Results:

• Novel flower-like micelles with a particle size of approximately 165 nm and CMC of 4 microg/ml were successfully developed.
• The micelles exhibited pH-responsive behavior, with the poly(DEAP-Lys) block transitioning from hydrophobic to hydrophilic upon protonation at pH < 7.0.
• Doxorubicin release was significantly accelerated at tumor extracellular pH (pH(e)) compared to physiological pH, demonstrating triggered release.

Conclusions:

• The developed flower-like micelles provide a promising platform for pH-triggered drug delivery.
• The unique structure and pH-responsive nature of poly(DEAP-Lys)-b-PEG-b-PLLA enable controlled drug release in acidic tumor environments.
• These micelles hold potential for improving the efficacy and reducing side effects of cancer chemotherapy.